Inventor · disambiguated record
Sridhar Vempati
Also filed as: VEMPATI SRIDHAR
8 granted patents·4 pending applications·36 citations·filing 2019–2024
82Inventor score
Top patents by PatentIndex Score
12 records- 0194US11702421B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2021·Granted Jul 18, 2023·6 cites·4 claims
- 0293US11084825B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2019·Granted Aug 10, 2021·19 cites·26 claims
- 0390US11174263B2Inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2019·Granted Nov 16, 2021·11 cites·25 claims
- 0483US12116371B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Oct 15, 2024·0 cites·14 claims
- 0582US2024376112A1N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINE CARBOXAMIDE AND USES THEREOFBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 0680US12077544B2Irreversible inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0776US12275739B2Inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Apr 15, 2025·0 cites·21 claims
- 0868US11986475B1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2023·Granted May 21, 2024·0 cites·28 claims
- 0968US11845753B2Inhibitors of menin-mll interactionBIOMEA FUSION INC·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
- 1060US2025206728A1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1146US2024374590A1Compositions and methods for treating cancerA2A PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1239US2023027854A1Isoxazole derivatives targeting tacc3 as anticancer agentsA2A PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sridhar Vempati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →